Skip to main content

Consolidation and Covid-19 blamed for insurtech investment 'slowdown'

piggy-bank-drowning

Consolidation and the global coronavirus pandemic have driven a slowdown in insurtech investment in the first quarter of the year, experts have cautioned, with the worst of the Covid-19 impact on funding yet to come.

Last week, Willis Towers Watson reported insurtech investment worldwide during quarter one, which saw almost the same amount of money raised in its first three days as was then subsequently raised in

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Q&A: Will Pritchett, Accenture UK and Ireland

Will Pritchett, insurance lead for Accenture UK and Ireland, talks to Insurance Post about how insurers can cope with changing demands as AI transforms the industry, and how the company’s role in supporting providers is evolving.

Axa aims to double schemes business

Sarah Mallaby, chief distribution officer and mid-market trading director at Axa Commercial, has revealed the provider is looking to double its schemes business as the firm looks to become a “£2bn business”.

Q&A: Fiona Marry, Bridgehaven

Fiona Marry, recently appointed European chief executive of Bridgehaven, tells Insurance Post about the company’s international expansion plans and what sets the hybrid model apart.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here